SE7711102L - Nya medel och nya sett att behandla klimakteriska bortfallsymptom - Google Patents

Nya medel och nya sett att behandla klimakteriska bortfallsymptom

Info

Publication number
SE7711102L
SE7711102L SE7711102A SE7711102A SE7711102L SE 7711102 L SE7711102 L SE 7711102L SE 7711102 A SE7711102 A SE 7711102A SE 7711102 A SE7711102 A SE 7711102A SE 7711102 L SE7711102 L SE 7711102L
Authority
SE
Sweden
Prior art keywords
oestrogen
daily dosages
daily
complete
dosages
Prior art date
Application number
SE7711102A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
U Lachnit-Fixson
F Neumann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7711102L publication Critical patent/SE7711102L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7711102A 1976-10-05 1977-10-04 Nya medel och nya sett att behandla klimakteriska bortfallsymptom SE7711102L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762645307 DE2645307A1 (de) 1976-10-05 1976-10-05 Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen

Publications (1)

Publication Number Publication Date
SE7711102L true SE7711102L (sv) 1978-04-06

Family

ID=5989934

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7711102A SE7711102L (sv) 1976-10-05 1977-10-04 Nya medel och nya sett att behandla klimakteriska bortfallsymptom

Country Status (9)

Country Link
AU (1) AU512918B2 (enrdf_load_stackoverflow)
BE (1) BE859410A (enrdf_load_stackoverflow)
CA (1) CA1090256A (enrdf_load_stackoverflow)
DE (1) DE2645307A1 (enrdf_load_stackoverflow)
DK (1) DK438077A (enrdf_load_stackoverflow)
GB (1) GB1578240A (enrdf_load_stackoverflow)
NL (1) NL7709742A (enrdf_load_stackoverflow)
SE (1) SE7711102L (enrdf_load_stackoverflow)
ZA (1) ZA775980B (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE3864210D1 (de) * 1987-07-06 1991-09-19 Akzo Nv Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0309263B1 (en) * 1987-09-24 1994-03-09 Jencap Research Limited Hormone composition and use
DE4019670A1 (de) * 1990-06-22 1992-01-09 Erhard Dr Med Roemer Arzneimittel zur behandlung der wechseljahre der frau
DE4104385C1 (enrdf_load_stackoverflow) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4308406C1 (de) * 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175468A (en) * 1967-10-19 1969-12-23 Merck Ag E Pharmaceutical Compositions
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
DE2529523C2 (de) * 1975-06-30 1987-04-30 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur Behandlung klimakterischer Ausfallerscheinungen

Also Published As

Publication number Publication date
DK438077A (da) 1978-04-06
CA1090256A (en) 1980-11-25
NL7709742A (nl) 1978-04-07
GB1578240A (en) 1980-11-05
AU512918B2 (en) 1980-11-06
AU2936477A (en) 1979-04-12
BE859410A (fr) 1978-04-05
DE2645307C2 (enrdf_load_stackoverflow) 1988-10-13
ZA775980B (en) 1978-05-30
DE2645307A1 (de) 1978-04-06

Similar Documents

Publication Publication Date Title
Brand et al. Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods
Lachman et al. The theory and practice of industrial pharmacy
SE7711102L (sv) Nya medel och nya sett att behandla klimakteriska bortfallsymptom
ATE5508T1 (de) Praeparate zur parenteralen verabreichung fettloeslicher wirkstoffe.
UA42806C2 (uk) Система для одночасного трансдермального введення кількох активних начал
GR76810B (enrdf_load_stackoverflow)
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
ES2087964T3 (es) Contraceptivos orales bajos en estrogenos.
GB1490099A (en) Contraceptive method and pack
ATE48598T1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alk nsaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
GB1433032A (en) Contraceptive method and preparations
TW261615B (enrdf_load_stackoverflow)
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
PT759693E (pt) Processos para a identificacao de compostos capazes de anular as interaccoes de ligacao de vpr-rip-1 de vih-1
ATE65912T1 (de) Arzneimittelzusammensetzungen ermaessigter toxizitaet.
Stambaugh et al. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy
Randle et al. Pityriasis rubra pilaris and celiac sprue with malabsorption
ES2062763T3 (es) Preparacion farmaceutica de 1-octadecil-2-metil-glicero-3-fosfocolina administrable por via intravenosa.
GB1483650A (en) Pharmaceutical preparations based on mesterolone
Mackenzie A comparison of IDU solution, IDU ointment, and carbolization in the treatment of dendritic corneal ulcer
BREITNER Marsilid in catatonic schizophrenia
Jacyk Septrin in the treatment of dermatitis cruris pustulosa et atrophicans
Brugarolas et al. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study
Marks et al. Peripheral neuropathy caused by methaqualone
GB1214712A (en) Contraceptive preparations

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7711102-9

Format of ref document f/p: F